RecruitingNot ApplicableNCT07509827

Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)


Sponsor

Institute of HIV Research and Innovation Foundation, Thailand

Enrollment

108 participants

Start Date

Aug 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.


Eligibility

Sex: MALEMin Age: 18 YearsMax Age: 29 Years

Inclusion Criteria7

  • Age 18-29 years
  • Male sex at birth
  • Self-identify as transgender woman/female spectrum
  • HIV-negative (laboratory confirmed)
  • Recent condomless sex
  • Able to understand Thai
  • Not on PrEP or poorly adherent (≤3 pills/week)

Exclusion Criteria4

  • Serious cognitive or psychiatric condition affecting consent
  • Active suicidal ideation or major mental illness
  • Medical contraindications to PrEP
  • Enrolled in another HIV intervention study

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALMobile Healthy Choices (mHC)+SPC

Intervention: * Behavioral: Mobile Healthy Choices (mHC) * Behavioral: Standard PrEP Counseling (SPC)

BEHAVIORALFRESH + SPC

Intervention: * Behavioral: FRESH (Finding Respect and Ending Stigma around HIV) * Behavioral: Standard PrEP Counseling (SPC)

BEHAVIORALmHC + FRESH + SPC

Intervention: * Behavioral: Mobile Healthy Choices (mHC) * Behavioral: FRESH * Behavioral: Standard PrEP Counseling (SPC)


Locations(3)

Rainbow Sky Association of Thailand (RSAT)

Bangkok, Bangkapi, Thailand

The Service Workers In Group Foundation (SWING)

Bangkok, Building 3, Patpong, Surawong Road, Thailand

Institute of HIV Research and Innovation (IHRI)

Bangkok, Pathumwan, Thailand

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07509827


Related Trials